Product Images Udenyca
View Photos of Packaging, Labels & Appearance
- image of UDENYCA before use - udenyca 01
- image of UDENYCA after use - udenyca 02
- image of storage - instructions for use - udenyca 02a
- image of removal from storage - instructions for use - udenyca 03
- image of opening UDENYCA - instructions for use - udenyca 04
- image of time to reach room temp - instructions for use - udenyca 05
- image of gathering supplies - instructions for use - udenyca 06
- image of proper hand washing - instructions for use - udenyca 07
- image of removal of UDENYCA from tray - instructions of use - udenyca 08
- image of visual inspection - instructions for use - udenyca 09
- image of injection site selection - instructions for use - udenyca 10
- image of cleaning injection site - instructions for use - udenyca 11
- image of removal of needle cap - instructions for use - udenyca 12
- image of position of fingers - instructions for use - udenyca 13
- image of pinching skin of injection site - instructions for use - udenyca 14
- image of proper needle insertion - instructions for use - udenyca 15
- image of injection finger positioning - instructions for use - udenyca 16
- image of plunger push - instructions for use - udenyca 17
- image of needle retraction - instructions for use - udenyca 18
- image of disposal - instructions for use - udenyca 19
- image of carton label - principal panel - udenyca 20
Product Label Images
The following 21 images provide visual information about the product associated with Udenyca NDC 70114-130 by Coherus Oncology, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
image of UDENYCA before use - udenyca 01
This appears to be a visual diagram labelled as "Figure 1". It shows different parts of a syringe, including the inspection window, needle cap label, needle safety guard, unactivated syringe finger grips, body, plunger head, and NEEdIS plunger. It is not clear what context or purpose this diagram serves without additional information.*
image of UDENYCA after use - udenyca 02
The text is a brief description of an image labeled as "Figure 2" which shows a Needle Safety Guard in its activated position.*
image of storage - instructions for use - udenyca 02a
image of removal from storage - instructions for use - udenyca 03
image of opening UDENYCA - instructions for use - udenyca 04
image of time to reach room temp - instructions for use - udenyca 05
image of gathering supplies - instructions for use - udenyca 06
This is a description of a Sharps Disposal Container.*
image of proper hand washing - instructions for use - udenyca 07
image of removal of UDENYCA from tray - instructions of use - udenyca 08
image of visual inspection - instructions for use - udenyca 09
image of injection site selection - instructions for use - udenyca 10
This text seems to be a diagram or illustration showing different areas of the body where injections can be given. The areas highlighted are the back of the upper arm, abdomen, upper outer buttock, and thigh, as shown in Figure 10. There is no further information available.*
image of cleaning injection site - instructions for use - udenyca 11
image of removal of needle cap - instructions for use - udenyca 12
image of position of fingers - instructions for use - udenyca 13
image of pinching skin of injection site - instructions for use - udenyca 14
image of proper needle insertion - instructions for use - udenyca 15
image of injection finger positioning - instructions for use - udenyca 16
image of plunger push - instructions for use - udenyca 17
image of needle retraction - instructions for use - udenyca 18
image of disposal - instructions for use - udenyca 19
image of carton label - principal panel - udenyca 20
UDENYCA (pegfilgrastim-cbav) is a sterile solution containing one mg/0.6mL of pegfilgrastim, a PEGylated recombinant human granulocyte colony-stimulating factor used to stimulate the production of white blood cells in cancer patients undergoing chemotherapy. It is administered subcutaneously and is derived from E. coli bacteria. It comes in prefilled syringes and there are five single dose injections in each package. No preservatives are present in the product.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
